Biotech Values

[DewDiligence]

MNTA – A few people on other boards recently asked what’s going on with the Lovenox patent case. This is what Craig Wheeler said on the 2Q08 CC held on 7/24/08 (#msg-31026200):

>>
“On June 27th, as expected, Sanofi-Aventis filed a petition for an en banc rehearing asking the full court, all nine judges, to reconsider the appellate decision.

Earlier in July, Teva and Amphastar were granted an extension until August 21st to file a response to the Sanofi-Aventis petition for rehearing. Furthermore, several parties, including Pharma and Bio, have filed amicus briefs in support of the petition for a rehearing. All of these actions are extending the period of time it will take for the court of appeals to consider the petition. Historic data suggests courts typically rule on a rehearing request within one to two months after the briefs are submitted. But there is no required timeline on the court.”
<<